Professor of Immune Modulation
Helmholtz Center Munich & LMU Munich, Germany
Prof. Dr. Carolin Daniel is a Principal Investigator at Helmholtz Munich, Munich/Germany, heading the Research Division Type 1 Diabetes Immunology (TDI). She also holds a Professorship for Immune modulation (W2) at Ludwig-Maximilians-University (LMU) Munich/Germany. She obtained a Ph.D. in Immune pharmacology from the European Graduate School of the German Research Foundation at the Goethe-University in Frankfurt (Germany) and the Karolinska-Institute in Stockholm (Sweden) in 2008. With a Fellowship from the Leopoldina/National-Academy-of-Sciences (Germany) she did a Post-Doc in Immunology at the Dana-Farber-Cancer-Institute in the laboratory of Harald von Boehmer and a joint appointment with Harvard-Medical-School, Boston (MA/USA) focusing on regulatory T cells in autoimmunity such as Type 1 Diabetes. She joined Helmholtz Munich as a Young Investigator Group leader in 2012 and received tenure as a group leader in 2016. Her work has been recognized with several awards and honours including an AcademiaNet Membership (European Database) for outstanding woman academics. Prizes and awards include among others the Ernst-Friedrich-Pfeiffer Prize of the German Diabetes Association (DDG), the Georges-Köhler-Prize of the German Association of Immunologists (DGfI), the Nils-Ilja-Richter Prize of the German Association for Autoimmune Diseases (DGfAE), the Early Career Research Prize in Vaccinology R&D of the International Union of Immunological Societies (IUIS), the Research Prize 2021 of the Heinz-Bürger-Büsing Foundation for the study of diabetes, the Ferdinand-Bertram-Prize of the German Diabetes Association (DDG), and the Isil Berat Barlan Award for Women Scholars in Immunology (ECI 2021).
Disclosure information not submitted.
Dissecting Regulatory T Cells in Autoimmune Type 1 Diabetes
Friday, June 23, 2023
9:00 AM - 9:30 AM
